8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 110
- Type
- D - Journal article
- DOI
-
10.1021/acs.jmedchem.5b01635
- Title of journal
- J Med Chem
- Article number
- -
- First page
- 1388
- Volume
- 59
- Issue
- 4
- ISSN
- 1520-4804
- Open access status
- Out of scope for open access requirements
- Month of publication
- January
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01635
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
42
- Research group(s)
-
-
- Citation count
- 50
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -